Immune-Related Adverse Events Effect in Metastatic Melanoma Treated With PD-1 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Impact of The Development of Immune Related Adverse Events in Metastatic Melanoma Treated with PD-1 Inhibitors
Melanoma Res. 2021 Jun 01;31(3)258-263, RG Holstead, BA Kartolo, WM Hopman, TD BaetzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.